S.No

Name of the Project

1.

Principal Investigator & National Coordinator

Efficacy and safety of immnuomodulator (Mycobacterium w) as an adjuvant therapy in Category II pulmonary tuberculosis patients along with immunological investigations (A multicenter study with a total cost of Rs. 526.54/- Lakhs)

Project registered with National Institute of Health (NCT00265226)

2

Principal Investigator & Coordinator

Efficacy and safety of immunomodulator Mw as an adjunct therapy in Category I Pulmonary Tuberculosis along with assessment of immunological parameters (Double-blind, Randomized, Placebo-Controlled, Clinical Trial)

Project registered with National Institute of Health (NCT00341328)

3

Principal Investigator

Efficacy of oral zinc administration as an adjunct therapy in Category I Pulmonary Tuberculosis along with assessment of immunological parameters (Double-blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial)

Project registered with National Institute of Health (NCT00698386)

4

Principal Investigator

Role of oral vitamin D as an adjunct therapy in Category I Pulmonary Tuberculosis along with assessment of immunological parameters (Double-blind, Randomized, Placebo-Controlled, Clinical Trial)

Project registered with National Institute of Health (NCT00507000)

5

Principal Investigator

Impact of HIV infection on latent TB among patients with HIV-TB co-infection (The site has been designated as National Facility)